Tirzepatide is a dual incretin receptor agonist widely researched for metabolic and glucose signalling pathways.
It is commonly studied for its interaction with GLP-1 and GIP receptors in laboratory models.
Tirzepatide is a synthetic peptide that acts as a dual agonist at glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors. In research settings, it is examined for its effects on insulin secretion models, appetite signalling pathways and lipid metabolism mechanisms. Laboratory studies have explored its role in glycaemic regulation research and adipose tissue signalling investigations. Due to its dual receptor activity, it is frequently utilised in experimental metabolic pathway studies.
Ready to order? Select your quantity above and add to bag.
Strictly for in vitro or qualified laboratory or animal research use only, not for human consumption or diagnostic or therapeutic application. Store refrigerated 2–8°C for stability. Shipped discreetly from the UK worldwide to research facilities.
Tirzepatide is a dual incretin receptor agonist widely researched for metabolic and glucose signalling pathways.
It is commonly studied for its interaction with GLP-1 and GIP receptors in laboratory models.
Tirzepatide is a synthetic peptide that acts as a dual agonist at glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors. In research settings, it is examined for its effects on insulin secretion models, appetite signalling pathways and lipid metabolism mechanisms. Laboratory studies have explored its role in glycaemic regulation research and adipose tissue signalling investigations. Due to its dual receptor activity, it is frequently utilised in experimental metabolic pathway studies.
Ready to order? Select your quantity above and add to bag.
Strictly for in vitro or qualified laboratory or animal research use only, not for human consumption or diagnostic or therapeutic application. Store refrigerated 2–8°C for stability. Shipped discreetly from the UK worldwide to research facilities.